The pharmaceutical industry is continually investigating innovative solutions for complex medical conditions. Among these advancements, FDA-Registered Peptides have emerged as a potential approach. , Particularly Apis, Liraglutide, Tirzepatide, and Semaglutide have gained significant acclaim for

Peptide companies in the United States have witnessed unprecedented growth, with the FDA approving a record number of peptide-based therapeutics in recent years. Indeed, these specialized molecules now account for over 5% of all approved drugs, underscoring their growing importance in modern medi